The Timken Company (TKR)
(Delayed Data from NYSE)
$82.24 USD
-0.58 (-0.70%)
Updated Oct 3, 2024 04:00 PM ET
After-Market: $82.26 +0.02 (0.02%) 7:58 PM ET
3-Hold of 5 3
B Value D Growth F Momentum C VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$82.24 USD
-0.58 (-0.70%)
Updated Oct 3, 2024 04:00 PM ET
After-Market: $82.26 +0.02 (0.02%) 7:58 PM ET
3-Hold of 5 3
B Value D Growth F Momentum C VGM
Zacks News
Here's Why Momentum Investors Will Love Timken (TKR)
by Zacks Equity Research
Does Timken (TKR) have what it takes to be a top stock pick for momentum investors? Let's find out.
Here's Why You Should Add Timken (TKR) to Your Portfolio
by Zacks Equity Research
A successful acquisition strategy, solid earnings growth prospects, estimate revision activity are among the few factors that make Timken (TKR) a prudent investment option.
Why Is Timken (TKR) Up 15.1% Since Last Earnings Report?
by Zacks Equity Research
Timken (TKR) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
5 Profitable Stocks to Boost Returns Using Net Income Ratio
by Nitish Marwah
Profitability analysis is one of the best ways to evaluate the prospects of a company.
NN to Divest Life Sciences Unit, To Pay Debts With Proceeds
by Zacks Equity Research
The divestment of NN's (NNBR) Life Sciences business will help it focus on high-growth opportunities in Mobile Solutions and Power Solutions divisions. Also, it will enable debt reduction and improvement in financial flexibility.
Timken's Shares March Higher, Can It Continue?
by Zacks Equity Research
As of late, it has definitely been a great time to be an investor in The Timken.
Moving Average Crossover Alert: The Timken Company
by Zacks Equity Research
The Timken Company is looking like an interesting pick from a technical perspective, as the company is seeing favorable trends on the moving average crossover front.
Timken (TKR) Q2 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
Timken (TKR) reports better-than-expected second-quarter results on lower operating expenses on cost reduction actions despite weak demand amid the COVID-19 pandemic.
Company News for Aug 4, 2020
by Zacks Equity Research
Companies In The News Are: TSN, MCK, MCY, TKR.
Timken (TKR) Q2 Earnings and Revenues Beat Estimates
by Zacks Equity Research
Timken (TKR) delivered earnings and revenue surprises of 209.09% and 13.93%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?
Earnings Preview: Timken (TKR) Q2 Earnings Expected to Decline
by Zacks Equity Research
Timken (TKR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Here's Why You Should Hold On to Timken (TKR) Stock for Now
by Zacks Equity Research
Timken (TKR) is worth retaining in the portfolio at the moment on its efforts to reduce costs, acquisitions and strengthen product offerings.
Why Is Timken (TKR) Up 13.2% Since Last Earnings Report?
by Zacks Equity Research
Timken (TKR) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Timken (TKR) Banks on Cost Saving Amid End-Market Weakness
by Zacks Equity Research
Timken (TKR) likely to benefit from cost-reduction initiatives despite the impact of the coronavirus pandemic on its operations and end markets.
Timken (TKR) Q1 Earnings Beat Estimates
by Zacks Equity Research
Timken (TKR) delivered earnings and revenue surprises of 3.74% and -0.78%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?
Analysts Estimate Timken (TKR) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Timken (TKR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Why Is Timken (TKR) Down 24.3% Since Last Earnings Report?
by Zacks Equity Research
Timken (TKR) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Timken's (TKR) Q4 Earnings Miss Estimates, Revenues Beat
by Zacks Equity Research
Timken (TKR) reports weaker-than-expected Q4 results on lower demand, mainly in the Mobile Industries segment, and higher manufacturing and SG&A costs.
Timken (TKR) Q4 Earnings Miss Estimates
by Zacks Equity Research
Timken (TKR) delivered earnings and revenue surprises of -11.58% and 1.43%, respectively, for the quarter ended December 2019. Do the numbers hold clues to what lies ahead for the stock?
Earnings Preview: Timken (TKR) Q4 Earnings Expected to Decline
by Zacks Equity Research
Timken (TKR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Timken's Shares Up 45% in a Year: What's Driving the Rally?
by Zacks Equity Research
Healthy growth prospects and upbeat outlook have contributed to Timken's (TKR) share rally.
Timken Rides on Positive Pricing & Buyouts Amid Cost Woes
by Zacks Equity Research
Timken (TKR) likely to benefit from favorable price and mix, acquisitions and cost-reduction initiatives despite higher input costs.
Timken (TKR) Earnings & Revenues Trail Estimates in Q3, Up Y/Y
by Zacks Equity Research
Timken (TKR) puts up stellar performance in Q3, aided by favorable price and mix, acquisition benefits, and lower material and logistics costs.
Timken (TKR) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
Timken (TKR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Timken (TKR) Stock Up 18% YTD: Will the Rally Continue?
by Zacks Equity Research
Timken (TKR) is likely to benefit from favorable price and mix, higher volumes and cost-reduction initiatives.